https://www.selleckchem.com/pr....oducts/gsk2141795.ht
ducing newer antimicrobials for targeting emerging resistance mechanisms in Gram-negative species. Critically ill coronavirus disease 2019 (COVID-19) patients need hospitalization which increases their risk of acquiring secondary bacterial and fungal infections. The practice of empiric antimicrobial prescription, due to limited diagnostic capabilities of many hospitals, has the potential to escalate an already worrisome antimicrobial resistance (AMR) situation in India. This study reports the prevalence and profiles of secondary infe
Like
Comment
Share
